LISTING AND QUOTATION NOTICE: NZX MAIN BOARD
TRUSCREEN LIMITED ORDINARY SHARES (“TRU”)

Company: TruScreen Limited

Issuer Code: TRU

ISIN: NZTRUE0001S7

Short Name: TruScreen

Registered Office: C/- HLB Mann Judd Limited,
Level 6, Equitable House,
57 Symonds Street,
Grafton,
Auckland

Website: www.truscreen.com

Telephone Number: +61 2 9262 4644

Financial Year End: 31 March

Nature of Business: TruScreen offers the latest technology in cervical screening, providing real-time, accurate detection of pre-cancerous and cancerous cervical cells to help improve the health and well-being of women around the world.

Directors: Anthony Ho (Chairman), Christopher Horn, Robert Hunter (William Hunter as his alternate), Kelly (Con) Hickey, Ronald Jones and Chris Lawrence

Details of Issue: Migration of the Listing and Quotation of TruScreen Limited ordinary shares from the NZX Alternative Market to the NZX Main Board.

Total Securities to be Quoted: 216,857,441 ordinary shares

Auditors: BDO Auckland

Solicitors: Jeremy Carr of Burton Partners

Share Registrar: Link Market Services Limited

Settlement Status: NZCDC Settlement System

Commencement of Trading on the NZX Main Board: 17 December 2018

Mark Peterson
Chief Executive Officer
NZX Limited

5 December 2018